Literature DB >> 8272253

Enhancement of the N-methyl-D-aspartate response in spinal dorsal horn neurons by cAMP-dependent protein kinase.

R Cerne1, K I Rusin, M Randić.   

Abstract

Glutamate-gated ion channels mediate excitatory synaptic transmission in the central nervous system and are involved in synaptic plasticity, neuronal development and excitotoxicity (5,24). These ionotropic glutamate receptors were classified according to their preferred agonists as AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), KA (kainate), and NMDA (N-methyl-D-aspartate) receptors [Trends Pharmacol. Sci., 11 (1990) 25-33]. The present study of NMDA receptor channels expressed in acutely isolated spinal dorsal horn (DH) neurons of young rat reveals that they are subject to modulation through the adenylate cyclase cascade. Whole-cell voltage-clamp recording mode was used to examine the effect of adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase (PKA) on the responses of DH neurons to NMDA. Whole-cell current response to NMDA was enhanced by 8 Br-cAMP, a membrane permeant analog of cAMP or by intracellular application of cAMP or catalytic subunit of PKA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272253     DOI: 10.1016/0304-3940(93)90275-p

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

Review 1.  Biochemical modulation of NMDA receptors: role in conditioned taste aversion.

Authors:  Beatriz Jiménez; Ricardo Tapia
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 2.  Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function.

Authors:  Ana Sanchez-Perez; Marta Llansola; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

3.  Interaction between metabotropic and NMDA subtypes of glutamate receptors in sprout suppression at young synapses.

Authors:  Frank Miskevich; Wei Lu; Shuh-Yow Lin; Martha Constantine-Paton
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

4.  Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons.

Authors:  Y N Wu; K Z Shen; S W Johnson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats.

Authors:  X Zou; Q Lin; W D Willis
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  Regular physical activity prevents development of chronic pain and activation of central neurons.

Authors:  Kathleen A Sluka; James M O'Donnell; Jessica Danielson; Lynn A Rasmussen
Journal:  J Appl Physiol (1985)       Date:  2012-12-27

7.  Separate intramolecular targets for protein kinase A control N-methyl-D-aspartate receptor gating and Ca2+ permeability.

Authors:  Teresa K Aman; Bruce A Maki; Thomas J Ruffino; Eileen M Kasperek; Gabriela K Popescu
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

8.  Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity.

Authors:  C Geoffrey Lau; Koichi Takeuchi; Alma Rodenas-Ruano; Yukihiro Takayasu; Jessica Murphy; Michael V L Bennett; R Suzanne Zukin
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

9.  Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones.

Authors:  S Rahman; R S Neuman
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Developmental switch in requirement for PKA RIIbeta in NMDA-receptor-dependent synaptic plasticity at Schaffer collateral to CA1 pyramidal cell synapses.

Authors:  Yupeng Yang; Koichi Takeuchi; Alma Rodenas-Ruano; Yukihiro Takayasu; Michael V L Bennett; R Suzanne Zukin
Journal:  Neuropharmacology       Date:  2008-08-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.